-
1 Comment
Inari Medical, Inc is currently in a long term downtrend where the price is trading 0.3% below its 200 day moving average.
From a valuation standpoint, the stock is 97.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 40.3.
Based on the above factors, Inari Medical, Inc gets an overall score of 1/5.
Industry | Medical Devices |
---|---|
Sector | Healthcare |
ISIN | US45332Y1091 |
CurrencyCode | USD |
Exchange | NASDAQ |
Target Price | 91.5 |
---|---|
PE Ratio | None |
Dividend Yield | 0.0% |
Beta | 1.1 |
Market Cap | 4B |
Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy systems for the specific disease states in the United States. The company provides ClotTriever, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for NARI using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024